Segment Information (Details) - USD ($) $ in Thousands	2 Months Ended	3 Months Ended	8 Months Ended	9 Months Ended
	Aug. 31, 2020	Sep. 30, 2019	Aug. 31, 2020	Sep. 30, 2019	Dec. 31, 2019
Segment Reporting Information [Line Items]
Revenues	$ 4,115	$ 8,031	$ 15,321	$ 22,185
Net Income (Loss) Attributable to Parent	4,398	(17,784)	(77,296)	(15,523)
Operating segment net income	3,104	(17,784)	(73,249)	(15,523)
Net income (loss) not allocated to a segment	1,294	0	(4,047)	0
Long-Lived Assets					$ 5,520
Income generating assets [Member]
Segment Reporting Information [Line Items]
Revenues	37	(45)	110	(39)
Net Income (Loss) Attributable to Parent	2,201	(7,600)	(37,217)	(26,790)
Long-Lived Assets					125
Pharmaceutical [Member]
Segment Reporting Information [Line Items]
Revenues	0	0	0	0
Net Income (Loss) Attributable to Parent	687	(2,123)	(15,855)	3,177
Long-Lived Assets					2,960
Medical devices [Member]
Segment Reporting Information [Line Items]
Revenues	4,078	8,076	15,211	22,224
Net Income (Loss) Attributable to Parent	216	(3,323)	(4,454)	(6,216)
Long-Lived Assets					2,435
Strategic positions [Member]
Segment Reporting Information [Line Items]
Revenues	0	0	0	0
Net Income (Loss) Attributable to Parent	0	(4,738)	$ (15,723)	$ 14,306
Long-Lived Assets					$ 0
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	$ 4,115	$ 8,031